This inventor holds 5 USPTO granted patents and 6 published patent applications. Top assignee: Washington University. Active years: 2012-2015.
Company Filing History:
Years Active: 2012-2015
Title: Innovations and Contributions of Kenneth M. Murphy
Introduction
Kenneth M. Murphy is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, particularly in the modulation of lymphocyte activity. With a total of 5 patents, his work has advanced our understanding of immune responses and therapeutic applications.
Latest Patents
One of Kenneth's latest patents is titled "Compositions and methods for modulating lymphocyte activity." This invention introduces a novel lymphocyte inhibitory receptor known as BTLA, which is expressed on both T and B cells. The patent identifies HVEM as an interacting partner with BTLA. Additionally, it provides methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM for therapeutic, diagnostic, and research purposes. Another significant patent is "Methods for inducing in vivo tolerance," which encompasses techniques for inducing tolerance to foreign tissue in vivo.
Career Highlights
Kenneth M. Murphy is affiliated with Washington University, where he continues to contribute to groundbreaking research in immunology. His work has not only led to innovative patents but has also influenced the scientific community's approach to immune modulation.
Collaborations
Some of Kenneth's notable coworkers include Theresa L. Murphy and Michelle A. Hurchla Pyles. Their collaborative efforts have further enriched the research environment at Washington University.
Conclusion
Kenneth M. Murphy's innovative contributions to immunology through his patents and research at Washington University highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in therapeutic applications and our understanding of immune responses.